Akt phosphorylation of mitochondrial Lonp1 protease enables oxidative metabolism and advanced tumor traits

scientific article published on 12 August 2019

Akt phosphorylation of mitochondrial Lonp1 protease enables oxidative metabolism and advanced tumor traits is …
instance of (P31):
scholarly articleQ13442814

External links are
P356DOI10.1038/S41388-019-0939-7
P932PMC publication ID6814529
P698PubMed publication ID31406245

P50authorE AgarwalQ55319427
Dario C AltieriQ98158352
P2093author name stringYuan Wang
David W Speicher
Jagadish C Ghosh
Jae Ho Seo
Hsin-Yao Tang
Andrew V Kossenkov
P2860cites workLandscape of the mitochondrial Hsp90 metabolome in tumoursQ37067115
Mitochondrial dynamics regulates migration and invasion of breast cancer cellsQ37548419
The mitochondrial UPR - protecting organelle protein homeostasisQ37806885
Dynamics of the ClpP serine protease: a model for self-compartmentalized proteasesQ38219190
Endoplasmic reticulum stress-activated cell reprogramming in oncogenesis.Q38482230
Proteostasis control by the unfolded protein responseQ38540196
Emerging role of Lon protease as a master regulator of mitochondrial functions.Q38795089
AKT/PKB Signaling: Navigating the NetworkQ39255027
A LON-ClpP Proteolytic Axis Degrades Complex I to Extinguish ROS Production in Depolarized Mitochondria.Q39675106
Regulation of tumor cell mitochondrial homeostasis by an organelle-specific Hsp90 chaperone network.Q40063505
LON is the master protease that protects against protein aggregation in human mitochondria through direct degradation of misfolded proteinsQ41811406
The Akt isoforms are present at distinct subcellular locationsQ43216821
AKT-mTOR signaling modulates the dynamics of IRE1 RNAse activity by regulating ER-mitochondria contacts.Q47126627
Mitochondrial Lon Protease and CancerQ47361687
Targeting the PI3K pathway in cancer: are we making headway?Q52672314
Mitochondria and Cancer.Q53198693
ATP-Dependent Lon Protease Controls Tumor Bioenergetics by Reprogramming Mitochondrial ActivityQ57082590
Mitochondria in cancer metabolism, an organelle whose time has come?Q88882190
Akt-mediated phosphorylation of MICU1 regulates mitochondrial Ca2+ levels and tumor growthQ90028792
LonP1 Differently Modulates Mitochondrial Function and Bioenergetics of Primary Versus Metastatic Colon Cancer CellsQ90431965
HIF-1 regulates cytochrome oxidase subunits to optimize efficiency of respiration in hypoxic cellsQ24302194
Mitochondrial ROS in cancer: initiators, amplifiers or an Achilles' heel?Q26852282
PI3K therapy reprograms mitochondrial trafficking to fuel tumor cell invasionQ27324467
Crystal structure of Lon protease: molecular architecture of gated entry to a sequestered degradation chamberQ27664441
Mitochondrial Lon protease in human disease and aging: Including an etiologic classification of Lon-related diseases and disordersQ28071866
The Warburg effect: 80 years onQ28076125
Adapting proteostasis for disease interventionQ28131818
Mitochondrial Akt Regulation of Hypoxic Tumor ReprogrammingQ28771755
MaxQuant enables high peptide identification rates, individualized p.p.b.-range mass accuracies and proteome-wide protein quantificationQ29547200
Molecular chaperones in protein folding and proteostasisQ29547715
Integrating the mechanisms of apoptosis induced by endoplasmic reticulum stressQ29615495
Modulation of oxidative stress as an anticancer strategyQ29615707
Mitochondria and cancerQ29616610
A neuronal network of mitochondrial dynamics regulates metastasisQ30833071
Organismal proteostasis: role of cell-nonautonomous regulation and transcellular chaperone signalingQ33917420
Mitochondrial Lon protease at the crossroads of oxidative stress, ageing and cancer.Q34493828
Turnover of mitochondrial steroidogenic acute regulatory (StAR) protein by Lon protease: the unexpected effect of proteasome inhibitors.Q34580480
Distinct quaternary structures of the AAA+ Lon protease control substrate degradation.Q34651849
Degradation of misfolded proteins in neurodegenerative diseases: therapeutic targets and strategiesQ35152946
Inhibition of the Mitochondrial Protease ClpP as a Therapeutic Strategy for Human Acute Myeloid Leukemia.Q35708954
Regulators of mitochondrial dynamics in cancerQ35929111
Adaptive mitochondrial reprogramming and resistance to PI3K therapy.Q36047440
The Mitochondrial Unfoldase-Peptidase Complex ClpXP Controls Bioenergetics Stress and Metastasis.Q36070569
Oxidative stress inhibits distant metastasis by human melanoma cellsQ36277720
Mitochondrial Lon regulates apoptosis through the association with Hsp60-mtHsp70 complex.Q36347232
MitoCarta2.0: an updated inventory of mammalian mitochondrial proteinsQ36434534
Slicing a protease: structural features of the ATP-dependent Lon proteases gleaned from investigations of isolated domainsQ36458536
Mitochondrial localization and the persistent migration of epithelial cancer cellsQ36824448
Hsp90 regulation of mitochondrial protein folding: from organelle integrity to cellular homeostasisQ37056146
P433issue43
P304page(s)6926-6939
P577publication date2019-08-12
P1433published inOncogeneQ1568657
P1476titleAkt phosphorylation of mitochondrial Lonp1 protease enables oxidative metabolism and advanced tumor traits
P478volume38